Hantavirus Pulmonary Syndrome: The new American hemorrhagic fever

Clinical Infectious Diseases

Volumn 34, Issue 9, 2002, Pages 1224-1231

  Peters, C J ^a   Khan, Ali S ^b  

^a University of Texas Medical Branch   (Georgia)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; GEOGRAPHIC DISTRIBUTION; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HUMAN; INFECTION PREVENTION; INFECTION RISK; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYNDROME DELINEATION; UNITED STATES; VIRUS HEMORRHAGIC FEVER;

ANIMALS; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER, AMERICAN; HUMANS; RATS; SIN NOMBRE VIRUS;

EID: 0036570359     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/339864     Document Type: Article

References (29)

1. Hantaviruses
2. Spectrum of hantavirus infection: Hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome
3. Hantavirus pulmonary syndrome: A clinical description of 17 patients with a newly recognized disease
4. Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States
5. The incubation period of hantavirus pulmonary syndrome
6. Hantavirus pulmonary syndrome: Pathogenesis of an emerging infectious disease
7. Hantavirus pulmonary syndrome in the United States: A pathological description of a disease caused by a new agent
8. Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome
9. Distinguishing hantavirus pulmonary syndrome from acute respiratory distress syndrome by chest radiography: Are there different radiographic manifestations of increased alveolar permeability?
10. Cardiopulmonary manifestations of hantavirus pulmonary syndrome
11. Successful treatment of adults with severe hantavirus pulmonary syndrome with extracorporeal membrane oxygenation
12. Systemic capillary leak syndrome: Report on 13 patients with special focus on course and treatment
13. Preliminary evidence for pulmonary dysfunction in survivors of hantavirus pulmonary syndrome
14. Neuropsychological impairments following hantavirus pulmonary syndrome
15. Hantavirus pulmonary syndrome in the Americas
16. Hantavirus pulmonary syndrome in southern Argentina
17. Genetic diversity, distribution, and serological features of hantavirus infection in five countries in South America
18. High levels of viremia in patients with the hantavirus pulmonary syndrome
19. Hantavirus pulmonary syndrome outbreak in Argentina: Molecular evidence for person-to-person transmission of Andes virus
20. Cellular receptors and hantavirus pathogenesis
21. Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells
22. + cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness
23. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome
24. Implications of the analogy between recombinant cytokine toxicities and manifestations of hantavirus infections
25. Humoral immune responses in the hantavirus cardiopulmonary syndrome
26. Cardiac involvement in dengue haemorrhagic fever
27. Pathogenesis of viral hemorrhagic fevers
28. A lethal dose model for hantavirus pulmonary syndrome
29. Hantavirus infection-southwestern United States: Interim recommendations for risk reduction